DARU-Journal of Pharmaceutical Sciences

Papers
(The TQCC of DARU-Journal of Pharmaceutical Sciences is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Hybrid derivatives containing dimethyl fumarate and benzothiazole scaffolds for the potential treatment of multiple sclerosis; in silico & in vivo study61
New psychoactive substances: a multidisciplinary review of challenges and their diverse character32
Multi-functionalization of reduced graphene oxide nanosheets for tumor theragnosis: Synthesis, characterization, enzyme assay, in-silico study, radiolabeling and in vivo targeting evaluation25
Dispersive micro-solid phase extraction based on two MOFs as highly effective adsorbents for analysis of nilotinib in plasma and wastewater23
Effect of vitamins C and E on cancer survival; a systematic review20
Lipid nanoparticles for gene therapy in ocular diseases19
Co-delivery of SN38 and rapamycin albumin bound nanoparticles against breast Cancer19
Pharmacogenetic DPYD allele variant frequencies: A comprehensive analysis across an ancestrally diverse Iranian population18
Evaluation of clinical and safety outcomes of generic tacrolimus (Suprotac $$\circledR$$) versus branded tacrolimus (Prograf $$\circledR$$) in de novo liver transplant patients: a randomized clinical 18
Stearyl amine tailored spanlastics embedded within tetronic® nanogel for boosting the repurposed anticancer potential of mebendazole: formulation, in vitro profiling, cytotoxicity assessment, and in v18
Oral regimen for high dose methotrexate urine alkalinization: a systematic review and meta-analysis17
The effect of physical activity on epileptic seizures and consequentlearning and memory impairment in electrical amygdala kindling model15
Impact of concerning excipients on animal safety: insights for veterinary pharmacotherapy and regulatory considerations15
Cleaning validation in pharmaceutical quality control laboratories: a structured protocol for contamination risk mitigation14
A comparison between SARS-CoV-1 and SARS-CoV2: an update on current COVID-19 vaccines13
Structure based exploration of mitochondrial alpha carbonic anhydrase inhibitors as potential leads for anti-obesity drug development12
The impact of Rosa dmascena Mill. on gastrointestinal disorders: a comprehensive analysis through clinical trials, systematic review, and meta-analysis11
Empowering the pharmaceutical industry by revolutionizing education11
Co-delivery of artemisinin and metformin via PEGylated niosomal nanoparticles: potential anti-cancer effect in treatment of lung cancer cells11
Electrochemical evaluation of nivolumab used in cancer treatment with differential pulse voltammetry: A novel approach with single-use pencil graphite electrode10
Comparative evaluation of different oral iron salts in the management of iron deficiency anemia9
Repurposing metformin as a potential anticancer agent using in silico technique9
Ropivacaine suppresses the progression of renal cell carcinoma through regulating the lncRNA RMRP/EZH2/CCDC65 axis9
Designing and psychometric evaluation of pharmacists' attitude toward ethical challenges questionnaire in pharmacy practice: A mixed‑method study9
In vitro evaluation of CeO2 nanoparticles on doxorubicin induced cardiotoxicity: focused on oxidative stress, inflammation, apoptosis, and mitochondrial function8
Alpinumisoflavone against cancer pro-angiogenic targets: In silico, In vitro, and In ovo evaluation8
Silymarin sensitizes human colorectal cancer cells to 5-ALA–mediated photodynamic therapy by enhancing cytotoxicity and apoptotic signaling in vitro7
Computational Screening Using a Combination of Ligand-Based Machine Learning and Molecular Docking Methods for the Repurposing of Antivirals Targeting the SARS-CoV-2 Main Protease7
High-performance liquid chromatography method for measuring Captopril: an empirical study on hydrogel film permeability test7
Amorphous solid dispersions as a strategy to enhance the bioavailability and stability of formulations containing plant active ingredients: An integrative review7
Vancomycin- induced leukocytoclastic vasculitis in a patient with end-stage renal disease: a case report and literature review7
Developing an AI-based prediction model for anaphylactic shock from injection drugs using Japanese real-world data and chemical structure-based analysis7
A neuroprotective dose of trehalose is harmless to metabolic organs: comprehensive histopathological analysis of liver, pancreas, and kidney6
From code to cure: AI-Driven innovation in monoclonal antibody development6
Network pharmacology: a systems perspective possible underpinning approach for oral cancer treatment6
Efficacy of dostarlimab in recurrent or advanced mismatch Repair-Deficient endometrial Cancer as a Single-Agent therapy: A systematic review and Meta-Analysis6
Adrenergic receptors blockade alleviates dexamethasone-induced neurotoxicity in adult male Wistar rats: Distinct effects on β-arrestin2 expression and molecular markers of neural injury6
Innovative triamcinolone acetonide microsuspension for Non-Invasive ocular management of inflammation6
Correction: Dexmedetomidine alleviates Hypoxia/reoxygenation-induced mitochondrial dysfunction in cardiomyocytes via activation of Sirt3/ Prdx3 pathway6
Trends analysis and future study of the pharmaceutical industry field: a scoping review6
Pre-emptive hydrocortisone therapy in early septic shock: a double-blind, allocation-concealed, pilot randomized controlled trial6
Correction: Flavonoid as possible therapeutic targets against COVID-19: a scoping review of in silico studies6
0.43749785423279